TNF antagonists

Details for Australian Patent Application No. 2005306168 (hide)

Owner Borean Pharma A/S

Inventors Andersen, Mikkel Holmen; Ottow, Helle Krogh; Nieland, Josephus Dirk; Holtet, Thor Las; Munch, Mette

Agent FB Rice

Pub. Number AU-A-2005306168

PCT Pub. Number WO2006/053568

Priority 60/629,343 22.11.04 US; PA 2004 01813 22.11.04 DK

Filing date 21 November 2005

Wipo publication date 26 May 2006

International Classifications

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/053568 Priority application(s): WO2006/053568

13 November 2008 Assignment before Grant

  Borean Pharma ApS The application has been assigned to Anaphore, Inc.

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306186-Immunotherapeutic formulations with Interleukin-2-neutralising capacity

2005306167-Compensation of simple fiberoptic faraday effect sensors